Rheumatology Network Interviews Clinical Investigator for the SELECT-COMPARE Trial for Rinovoq

Roy M. Fleischmann, MD and primary investigator for SELECT-COMPARE, the phase III clinical trial of Rinovoq, AbbVie’s oral once-daily JAK inhibitor for adults with moderate to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. In this article the Rheumatology Network’s Amy Reyes interview’s Dr. Fleischmann, the clinical professor at … Continue reading Rheumatology Network Interviews Clinical Investigator for the SELECT-COMPARE Trial for Rinovoq